Hyperoxia and Pulmonary Complications After Cardiac Surgery

Overview

The main objective is to demonstrate that hyperoxia in cardiac surgery increase the occurrence of post-operative pulmonary complications

Full Title of Study: “Hyper-Cardia Study : Hyperoxia and Pulmonary Complications After Cardiac Surgery”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Retrospective
  • Study Primary Completion Date: September 5, 2020

Clinical Trial Outcome Measures

Primary Measures

  • Retrospective study of the average of per and postoperative PaO2 in cardiac surgery
    • Time Frame: iles analyzed retrospectily from January 1st, 2015 to December 31, 2019 will be examined

Participating in This Clinical Trial

Inclusion Criteria

  • Adult patient (≥18 years old) – Patient operated heart surgery with extra-corporal life support – Hospitalization in Cardiology intensive and critical care unit – Patient operated in HUS between 01/01/2015 and 31/12/2019 – Subject consent, after information, to the reuse of its data for the purposes of this study Exclusion Criteria:

  • Non-consent patient – Hypoxemic patient – Emergency surgery – Patient with post-operative cardiac assist device – Patient with guardianship

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Investigator Details

  • Lead Sponsor
    • University Hospital, Strasbourg, France
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • François FISCHER, MD, Study Director, University Hospital, Strasbourg, France

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.